Hepatitis C among Egyptian Patients Referred for Bone Marrow Examination: Seroprevalence and Analysis of Hematological Findings

Table 1

Clinical and hematological parameters of HCV positive (𝑛=42) and HCV negative patients (𝑛=58).

Parameter	HCV positive patients	HCV negative patients	𝑃
Age (mean ± SD years)	47.38 ± 11.64	39.91 ± 15.47	0.01*
Males 𝑛 (%)	21 (50)	29 (50)	1.00
Splenomegaly 𝑛 (%)	32 (76)	30 (52)	0.02*
Hepatomegaly 𝑛 (%)	15 (36)	16 (28)	0.52
Lymphadenopathy 𝑛 (%)	4 (10)	12 (21)	0.22
Hb% (mean ± SD g/dL)	9.73 ± 2.50	8.91 ± 3.00	0.15
RBCs (mean ± SD ×10^6/μL)	3.45 ± 0.99	3.17 ± 1.17	0.21
MCV (mean ± SD fL)	85.61 ± 10.89	85.16 ± 9.45	0.83
MCH (mean ± SD pg)	28.47 ± 4.69	28.65 ± 3.59	0.83
TLC (mean ± SD ×10^3/μL)	5.02 ± 3.64	8.92 ± 19.37	0.20
Platelets (mean ± SD ×10^3/μL)	72.71 ± 63.41	138.48 ± 187.60	0.03*

HCV: hepatitis C virus, Hb: hemoglobin, RBCs: red blood cells, MCV: mean corpuscular volume, fL: femtoliter, MCH: mean corpuscular hemoglobin, pg: picogram, TLC: total leukocyte count, ∗a statistically significant value.